Crossmark

Durvalumab and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant

Published Online: 2022-11-18

Published Print: 2023-02

Authors

Ryan, Carrie E.

Lambdin, Jacob

Shah, Shimul

Quillin, Ralph Cutler

Lemon, Kristina

Hernandez, Jonathan M.

Sohal, Davendra
License Information

Text and Data Mining valid from 2022-11-18

Version of Record valid from 2022-11-18
More Information

Article History

Received: 12 October 2022

Accepted: 1 November 2022

First Online: 18 November 2022

Document is current